EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Novel Compound Heterozygous Variants in TGM1 and CYP4F22 in Two Newborns with Non-Syndromic Epidermal Differentiation Disorders (TGM1-nEDD and CYP4F22-nEDD)

Gregorio Serra iD, Giovanni Barbera, Vincenzo Antona, Danilo Malizia, Iria Neri, Enrico Perre iD, Maria Piccione, Annalisa Vetro iD, Alessandra Vancini, Mario Giuffrè iD, Giovanni Corsello

Journal of Clinical Medicine · 15.07.2026 · 15 (14) · 5556

DOI: 10.3390/jcm15145556 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.07.2026. Verfasst von Gregorio Serra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Intensive Care Unit, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Department of Health Promotion, Mother and Child Care, …. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital ichthyoses are a clinically and genetically heterogeneous group of Mendelian disorders of cornification. According to the 2025 classification, non-syndromic epidermal differentiation disorders (nEDDs) are categorized based on the biological function of the causative gene products. Variants in TGM1 cause a transglutaminase-related nEDD (TGM1-nEDD), typically corresponding to the traditional phenotype of lamellar ichthyosis (LI), whereas biallelic variants in CYP4F22 cause a lipid-metabolism-related nEDD (CYP4F22-nEDD), formerly classified as ARCI type 5. The latter form is characterized by impaired acylceramide synthesis and epidermal barrier dysfunction. Although CYP4F22-nEDD usually follows a persistent course, considerable phenotypic variability has been reported, including milder forms and self-improving collodion ichthyosis. Methods and Results: We report two unrelated Italian neonates with congenital ichthyosis, investigated by targeted next-generation sequencing (NGS). Patient 1 presented with a phenotype consistent with LI and carried compound heterozygous TGM1 variants: the known pathogenic c.1147G>A p.(Val383Met) variant, and the novel c.860C>T p.(Thr287Ile) variant, classified as likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) criteria. Patient 2 presented as a collodion baby and carried two heterozygous CYP4F22 variants: the known pathogenic nonsense variant c.1084C>T p.(Arg362Ter), and the previously unreported in-frame deletion c.543_545del p.(Ile181del), currently classified as a variant of uncertain significance (VUS). Because parental segregation analysis was unavailable, the allelic phase of the CYP4F22 variants could not be established, and molecular confirmation of autosomal recessive inheritance was not possible. Both patients showed marked clinical improvement during follow-up with topical emollient therapy alone. In Patient 2, the clinical course was consistent with a self-improving collodion ichthyosis phenotype. A structured literature review was performed to contextualize the clinical and molecular findings.

Conclusions

These cases illustrate the clinical and genetic heterogeneity of nEDDs, and confirm the value of NGS in the management of neonates with congenital ichthyosis. The principal novelty of this report lies in the identification of previously unreported TGM1 and CYP4F22 sequence variants. While functional validation is lacking, integration of clinical and genetic findings with literature evidence may assist interpretation of rare variants and support genetic counselling.

Schlagwörter

Stichwörter der Autor:innen

CYP4F22TGM1collodion babylamellar ichthyosisnovel mutationself-improving collodion ichthyosistargeted NGS

Autor:innen und Institutionen

  • Neonatal Intensive Care Unit, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", Universit…
  • Dermatology Unit, Sant'Orsola-Malpighi Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, 40138 Bologna, Italy.
  • Neonatal Intensive Care Unit, Maggiore Hospital "Carlo Alberto Pizzardi", AUSL Bologna, 40133 Bologna, Italy.
  • Genetics Laboratory, Medical Genetics Operative Unit, Villa Sofia-Cervello Joint Hospitals, University of Palermo, 90146 Palermo, Italy.

ORCID-Profile: Gregorio Serra, Enrico Perre, Annalisa Vetro, Mario Giuffrè

Zitieren

APA

Serra, G., Barbera, G., Antona, V., Malizia, D., Neri, I., Perre, E., Piccione, M., Vetro, A., Vancini, A., Giuffrè, M., & Corsello, G. (2026). Novel Compound Heterozygous Variants in TGM1 and CYP4F22 in Two Newborns with Non-Syndromic Epidermal Differentiation Disorders (TGM1-nEDD and CYP4F22-nEDD). Journal of Clinical Medicine, 15(14), 5556. https://doi.org/10.3390/jcm15145556

Vancouver

Serra G, Barbera G, Antona V, Malizia D, Neri I, Perre E, et al. Novel Compound Heterozygous Variants in TGM1 and CYP4F22 in Two Newborns with Non-Syndromic Epidermal Differentiation Disorders (TGM1-nEDD and CYP4F22-nEDD). Journal of Clinical Medicine. 2026;15(14):5556. doi:10.3390/jcm15145556

BibTeX
@article{Serra2026,
  author = {Serra, Gregorio and Barbera, Giovanni and Antona, Vincenzo and Malizia, Danilo and Neri, Iria and Perre, Enrico and Piccione, Maria and Vetro, Annalisa and Vancini, Alessandra and Giuffrè, Mario and Corsello, Giovanni},
  title = {Novel Compound Heterozygous Variants in TGM1 and CYP4F22 in Two Newborns with Non-Syndromic Epidermal Differentiation Disorders (TGM1-nEDD and CYP4F22-nEDD)},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {5556},
  doi = {10.3390/jcm15145556}
}
Kostenlos starten →